TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 1 | 2 | 2 | 10 | 17 | 12 | 7 |
| S | %wins | 33 | 33 | 33 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/15/06 15:26 | 11/13/06 | IART | Integra Lifesciences Holdings Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Holtz David B | NJ | O | SVP,Fina | S.dm | -3,775 | 40.15 | 7 | -94 | -90 | 10 | D | 14 | 18 | 8 | 13 | 5 | 9 | 3 | 3 | 1 | 2 | 6 | 9 | 23 | 4 |
11/17/05 15:24 | 11/15/05 | IART | Integra Lifesciences Holdings Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Holtz David B | NJ | O | SVP,Fina | S.dm | -592 | 34.31 | 8 | -17 | -50 | 18 | D | 6 | -1 | 2 | 3 | -8 | -5 | 1 | 1 | 3 | 5 | 5 | 16 | 9 | 19 |
9/13/04 16:52 | 9/10/04 | IART | Integra Lifesciences Holdings Corp | DE | Health | BioPrd | Biological Products, (No Diag | Holtz David B | NJ | O | SVP,Fina | S.d | -253 | 31.75 | 6 | -8 | -33 | 16 | D | 104 | 13 | 1 | -2 | 1 | 9 | 7 | 6 | 0 | -1 | -4 | 5 | 19 | 13 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |